Brief: Karolinska Development: Portfolio Company Pharmnovo's Drug Candidate PN6047 In NIDA Funded Collaboration

Kdventures AB

04/12/2023 07:59

Dec 4 (Reuters) - Karolinska Development AB  KDEV.ST :
    * REG-KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY PHARMNOVO'S
DRUG
CANDIDATE PN6047 IN A NIDA FUNDED COLLABORATION
    * INTEREST IN PN6047 REFLECTS NIDA'S EFFORTS TO FIND
EFFECTIVE
TREATMENTS FOR OPIOID WITHDRAWAL TO TACKLE PERSISTENT CHALLENGE
OF OPIOID ADDICTION

Source text for Eikon:  ID:nGNE9hHDPY 
Further company coverage:  KDEV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))